Watanabe T, Hatayama N, Guo M, Yuhara S, Shinoka T
Bioengineering (Basel). 2024; 11(10).
PMID: 39451329
PMC: 11505552.
DOI: 10.3390/bioengineering11100954.
Wang Z, Liu X, Shi X, Wang Y
Regen Biomater. 2024; 11:rbae094.
PMID: 39350955
PMC: 11441758.
DOI: 10.1093/rb/rbae094.
Waldron C, Kelly L, Stan N, Kawakami Y, Abrahante J, Magli A
Stem Cells Transl Med. 2024; 13(7):678-692.
PMID: 38761090
PMC: 11227970.
DOI: 10.1093/stcltm/szae032.
Lim J, Fang H, Bupphathong S, Sung P, Yeh C, Huang W
ACS Biomater Sci Eng. 2024; 10(6):3548-3567.
PMID: 38712543
PMC: 11167599.
DOI: 10.1021/acsbiomaterials.3c01978.
Aziz R, Falanga M, Purenovic J, Mancini S, Lamberti P, Guida M
Nanomaterials (Basel). 2023; 13(8).
PMID: 37110959
PMC: 10145986.
DOI: 10.3390/nano13081374.
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Zhou J, Cui B, Wang X, Wang H, Zheng J, Guo F
Stem Cell Res Ther. 2023; 14(1):92.
PMID: 37061738
PMC: 10105952.
DOI: 10.1186/s13287-023-03312-9.
Leaf-venation-directed cellular alignment for macroscale cardiac constructs with tissue-like functionalities.
Mao M, Qu X, Zhang Y, Gu B, Li C, Liu R
Nat Commun. 2023; 14(1):2077.
PMID: 37045852
PMC: 10097867.
DOI: 10.1038/s41467-023-37716-1.
High cell density and high-resolution 3D bioprinting for fabricating vascularized tissues.
You S, Xiang Y, Hwang H, Berry D, Kiratitanaporn W, Guan J
Sci Adv. 2023; 9(8):eade7923.
PMID: 36812321
PMC: 9946358.
DOI: 10.1126/sciadv.ade7923.
Biological Scaffolds for Congenital Heart Disease.
Harris A, Salih T, Ghorbel M, Caputo M, Biglino G, Carrabba M
Bioengineering (Basel). 2023; 10(1).
PMID: 36671629
PMC: 9854830.
DOI: 10.3390/bioengineering10010057.
Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
Lou X, Tang Y, Ye L, Pretorius D, Fast V, Kahn-Krell A
Cardiovasc Res. 2023; 119(4):1062-1076.
PMID: 36647784
PMC: 10153642.
DOI: 10.1093/cvr/cvad004.
Direct reprogramming of cardiomyocytes into cardiac Purkinje-like cells.
Prodan N, Ershad F, Reyes-Alcaraz A, Li L, Mistretta B, Gonzalez L
iScience. 2022; 25(11):105402.
PMID: 36388958
PMC: 9646947.
DOI: 10.1016/j.isci.2022.105402.
Large-Scale Production of Wholly Cellular Bioinks via the Optimization of Human Induced Pluripotent Stem Cell Aggregate Culture in Automated Bioreactors.
Ho D, Lee S, Du J, Weiss J, Tam T, Sinha S
Adv Healthc Mater. 2022; 11(24):e2201138.
PMID: 36314397
PMC: 10234214.
DOI: 10.1002/adhm.202201138.
Challenges and opportunities for the next generation of cardiovascular tissue engineering.
Cho S, Discher D, Leong K, Vunjak-Novakovic G, Wu J
Nat Methods. 2022; 19(9):1064-1071.
PMID: 36064773
DOI: 10.1038/s41592-022-01591-3.
Artificial Scaffolds in Cardiac Tissue Engineering.
Roacho-Perez J, Garza-Trevino E, Moncada-Saucedo N, Carriquiry-Chequer P, Valencia-Gomez L, Matthews E
Life (Basel). 2022; 12(8).
PMID: 35892919
PMC: 9331725.
DOI: 10.3390/life12081117.
Electrospun Carbon Nanotube-Based Scaffolds Exhibit High Conductivity and Cytocompatibility for Tissue Engineering Applications.
Suh T, Twiddy J, Mahmood N, Ali K, Lubna M, Bradford P
ACS Omega. 2022; 7(23):20006-20019.
PMID: 35721944
PMC: 9202252.
DOI: 10.1021/acsomega.2c01807.
Recent Advances in Development of Natural Cellulosic Non-Woven Scaffolds for Tissue Engineering.
Aghazadeh M, Delfanian S, Aghakhani P, Homaeigohar S, Alipour A, Shahsavarani H
Polymers (Basel). 2022; 14(8).
PMID: 35458282
PMC: 9030052.
DOI: 10.3390/polym14081531.
Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design.
Fassina D, M Costa C, Longobardi S, Karabelas E, Plank G, Harding S
PLoS Comput Biol. 2022; 18(4):e1010030.
PMID: 35363778
PMC: 9007348.
DOI: 10.1371/journal.pcbi.1010030.
2D Materials for Cardiac Tissue Repair and Regeneration.
Gokce C, Gurcan C, Delogu L, Yilmazer A
Front Cardiovasc Med. 2022; 9:802551.
PMID: 35224044
PMC: 8873146.
DOI: 10.3389/fcvm.2022.802551.
Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.
Silver S, Barrs R, Mei Y
Front Cardiovasc Med. 2021; 8:707890.
PMID: 34820426
PMC: 8606657.
DOI: 10.3389/fcvm.2021.707890.
Bioengineering approaches to treat the failing heart: from cell biology to 3D printing.
Yadid M, Oved H, Silberman E, Dvir T
Nat Rev Cardiol. 2021; 19(2):83-99.
PMID: 34453134
DOI: 10.1038/s41569-021-00603-7.